Browsed by
Author: Member Success

IPS Acquires Linesight and Partners for Strategic Growth

IPS Acquires Linesight and Partners for Strategic Growth

BLUE BELL, PA, USA & DUBLIN, IRELAND, October 18th, 2021 – IPS-Integrated Project Services, LLC, headquartered in Blue Bell, Pennsylvania and a subsidiary of Alleghany Capital Corporation, today announced that it has acquired Linesight, a multinational consulting firm headquartered in Dublin, Ireland. IPS is a large EPCMV (Engineering, Procurement, Construction Management and Validation) company with over 1,700 staff across 22 offices worldwide. ...  Read more

BioFactura is on Course to Become a Global Leader in Biosimilar Development

BioFactura is on Course to Become a Global Leader in Biosimilar Development

Since the approval of the first biosimilar drug in the United States six years ago, the market has rapidly expanded and is expected to grow to approximately $23 billion in the U.S. by 2027. And Maryland’s BioFactura anticipates it will be one of the companies at the forefront of this revolution of new medications. ...  Read more

FITCI’s Nanobiofab shapes medical training with AI-powered platform

FITCI’s Nanobiofab shapes medical training with AI-powered platform

Tao Treasures LLC DBA Nanobiofab, a minority woman-owned nanotech startup in the Frederick Innovative Technology Center, Inc. (FITCI), is helping medical mannequins tell doctors where it hurts. The company, which creates revolutionary million-scale nanomaterial used in applications ranging from routine health monitoring to cancer detection, is working with West Virginia University (WVU) to improve clinical simulators. The million-dollar effort, initiated through the Defense Health Agency Small Business Innovation Research (SBIR) program, starts in September at Nanobiofab (Frederick, MD) and the David and Jo Ann Shaw Center for Simulation Training and Education for Patient Safety (STEPS) at WVU in Morgantown, WV. ...  Read more

Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa

Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa

Three-year contract leading to advance clinical trials for Lassa Fever vaccines reaffirms Zalgen’s focus on preparedness and its dedication to developing solutions for emerging viral threats

 Oslo, Norway & Germantown, Maryland, August 25, 2021 – Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on preparedness for high impact, neglected infectious diseases including Lassa Fever (LF), today announced its contract with the Coalition for Epidemic Preparedness Innovations (CEPI) to further advance the development of vaccines against Lassa Fever (LF) in West Africa, a region where the disease is endemic. ...  Read more

For The 5th Time, Verity Commercial Appears on The Inc. 5000 List of America’s Fastest-Growing Private Companies

For The 5th Time, Verity Commercial Appears on The Inc. 5000 List of America’s Fastest-Growing Private Companies

For the 5th time, Verity Commercial ranked on the Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. Verity’s multidisciplinary business platform and a strong focus on the wellness of its people and clients were key to maintaining stability and growth. ...  Read more

FZata Announces First-in-Class “Live Biologics In A Pill” Platform Entering Manufacturing Phase

FZata Announces First-in-Class “Live Biologics In A Pill” Platform Entering Manufacturing Phase

FZata, Inc. is developing a ground-breaking “Live Biologics In A Pill” platform for oral delivery of live biologics. Live Biologics In A Pill will open up a new route of oral administration for innovative live biologic therapeutics. FZata is pleased to announce that our lead drug, FZ002, has advanced to manufacturing stage and IND-enabling studies. ...  Read more

Bristol Myers Squibb and Five Leading Historically Black Colleges and Universities Launch Tomorrow’s Innovators to Create Custom Biopharma Educational Programming and Increase Recruitment of Black Talent in the Biopharma Industry

Bristol Myers Squibb and Five Leading Historically Black Colleges and Universities Launch Tomorrow’s Innovators to Create Custom Biopharma Educational Programming and Increase Recruitment of Black Talent in the Biopharma Industry

PRINCETON, N.J.–(BUSINESS WIRE)– Despite representing roughly 12% of the U.S. adult population, in biopharma, Black professionals account for just 7% of the total workforce and 3% of executive teams. Today, in an initiative designed to increase access to and awareness of the biopharma industry among Black talent and build a diverse talent pipeline, Bristol Myers Squibb (NYSE: BMY) announced its collaboration to launch Tomorrow’s Innovators—a multimillion dollar strategic alliance to attract top HBCU-affiliated talent to the bio-pharma industry in the next five years. ...  Read more